530665 Stock Overview
Manufactures and trades pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Zenith Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5.39 |
| 52 Week High | ₹6.87 |
| 52 Week Low | ₹3.61 |
| Beta | 1.64 |
| 11 Month Change | 8.02% |
| 3 Month Change | -2.18% |
| 1 Year Change | 29.88% |
| 33 Year Change | -21.43% |
| 5 Year Change | 334.68% |
| Change since IPO | 498.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530665 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.3% | -0.2% | 0.3% |
| 1Y | 29.9% | 40.5% | 27.3% |
Return vs Industry: 530665 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 530665 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 530665 volatility | |
|---|---|
| 530665 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530665 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 530665's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 40 | Mahendra Raycha | www.zenithhealthcare.com |
Zenith Healthcare Limited manufactures and trades pharmaceutical formulations in India. The company offers its products in the form of tablets, capsules, oral liquids, and injections in various therapeutic areas. It also engages in the contract manufacturing of various dosage forms.
Zenith Healthcare Limited Fundamentals Summary
| 530665 fundamental statistics | |
|---|---|
| Market cap | ₹289.65m |
| Earnings (TTM) | ₹1.04m |
| Revenue (TTM) | ₹130.26m |
279.6x
P/E Ratio2.2x
P/S RatioIs 530665 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530665 income statement (TTM) | |
|---|---|
| Revenue | ₹130.26m |
| Cost of Revenue | ₹65.58m |
| Gross Profit | ₹64.69m |
| Other Expenses | ₹63.65m |
| Earnings | ₹1.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.019 |
| Gross Margin | 49.66% |
| Net Profit Margin | 0.80% |
| Debt/Equity Ratio | 0% |
How did 530665 perform over the long term?
See historical performance and comparison